SCHEMBL718547

SCHEMBL718547

COc1c[c]c(F)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.41
GAA P10253 2/20 0.41
TAAR1 Q96RJ0 1/20 0.35
NPSR1 Q6W5P4 3/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
ALDH1A1 P00352 3/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
GLA P06280 1/20 0.34
MAPT P10636 4/20 0.33
RAB9A P51151 3/20 0.33
MAPK1 P28482 2/20 0.33
KDM4E B2RXH2 1/20 0.33
HSP90AA1 P07900 1/20 0.33
PKM P14618 1/20 0.33
CCR6 P51684 1/20 0.33
CACNA1B Q00975 1/20 0.33
APBA1 Q02410 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2344135 0.83 GAA (0.41) NPC1GAATAAR1NPSR1LMNA
SCHEMBL7740056 0.83 L3MBTL1 (0.42) NPC1SMN1; SMN2ALDH1A1MAPTRAB9A
SCHEMBL7740050 0.81 RAB9A (0.38) NPC1GAALMNASMN1; SMN2ALDH1A1
SCHEMBL1299376 0.80 CYP3A4 (0.37) LMNAALDH1A1MAPTRAB9AMAPK1
SCHEMBL27314988 0.80
SCHEMBL1531081 0.79 CSNK2A1 (0.41) GAALMNAALDH1A1MEN1KMT2A
SCHEMBL5843254 0.79 MAPT (0.37) NPSR1LMNASMN1; SMN2ALDH1A1KMT2A
SCHEMBL2351921 0.78 RAB9A (0.37) NPC1LMNASMN1; SMN2ALDH1A1MEN1
SCHEMBL1095882 0.78 GAA (0.43) NPC1GAATAAR1NPSR1SMN1; SMN2
SCHEMBL5844789 0.78 L3MBTL1 (0.44) NPC1NPSR1SMN1; SMN2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104093709-B It is used as the imidazole derivative of aldosterone synthase inhibitors 霍夫曼-拉罗奇有限公司 2017-09-22 CN claimed
CN-104093709-A Imidazolylketone derivatives as aldosterone synthase inhibitors HOFFMANN LA ROCHE 2014-10-08 CN claimed
US-20140100194-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA, NV (BE) 2014-04-10 US claimed
US-8558011-B2 Cold menthol receptor-1 antagonists JANSSEN PHARMACEUTICA, NV (BE) 2013-10-15 US claimed
EP-2029614-B1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2013-01-23 EP claimed
US-20120053347-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2012-03-01 US claimed
EP-2029614-A2 COLD MENTHOL RECEPTOR-1 ANTAGONISTS Janssen Pharmaceutica, N.V. (BE) 2009-03-04 EP claimed
US-20080287398-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2008-11-20 US claimed
US-20080027029-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2008-01-31 US claimed
WO-2007134107-A2 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2007-11-22 WO claimed
US-4859228-A Novel 5-aminomethylene-2,4-imidazolidinediones and 5-aminomethylene-2-thionoimidazolidine-4-ones ICI AMERICAS INC (US) 1989-08-22 US claimed
EP-0300882-A2 Novel 5-Aminomethylene-2,4-imidazolidinediones and 5-aminomethylene-2-thionoimidazolidine-4-ones ICI AMERICAS INC. (US) 1989-01-25 EP claimed
US-20230083973-A1 SUBSTITUTED CYCLOPROPYL-2,2'-BIPYRIMIDINYL COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2023-03-16 US disclosed
EP-4007578-A1 SUBSTITUTED CYCLOPROPYL-2,2'-BIPYRIMIDINYL COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME Arbutus Biopharma, Inc. (US) 2022-06-08 EP disclosed
WO-2021025976-A1 SUBSTITUTED CYCLOPROPYL-2,2'-BIPYRIMIDINYL COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2021-02-11 WO disclosed
CN-104093709-B It is used as the imidazole derivative of aldosterone synthase inhibitors 霍夫曼-拉罗奇有限公司 2017-09-22 CN disclosed
EP-0177553-A4 HERBICIDAL 1-ARYL-DELTA 2-1,2,4-TRIAZOLIN-5-ONES. FMC CORP (US) 1986-08-21 EP disclosed
EP-0177553-A1 HERBICIDAL 1-ARYL-DELTA 2-1,2,4-TRIAZOLIN-5-ONES FMC Corporation (US) 1986-04-16 EP disclosed
WO-1985004307-A1 HERBICIDAL 1-ARYL-DELTA2-1,2,4-TRIAZOLIN-5-ONES FMC CORPORATION (US) 1985-10-10 WO disclosed
EP-0070389-A2 2-(2-Fluoro-4-halo-5-substituted phenyl) hydantoins, and their production and use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1983-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027029-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS TRPM8, TRPM5, TRPM7 NPC1 418/4885GAA 2871/4885TAAR1 171/4885
US-20120053347-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS TRPM8, TRPM5, TRPM7 NPC1 418/4885GAA 2871/4885TAAR1 171/4885
US-20080287398-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS TRPM8, TRPM5, TRPM7 NPC1 418/4885GAA 2871/4885TAAR1 171/4885
US-20230083973-A1 SUBSTITUTED CYCLOPROPYL-2,2'-BIPYRIMIDINYL COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME HAVCR2, CDV3, HMBS NPC1 1054/4885GAA 3398/4885TAAR1 4786/4885
US-20140100194-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS TRPM8, TRPM5, TRPM7 NPC1 418/4885GAA 2871/4885TAAR1 171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.